ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES

1974/11/01 by GianFranco Bottazzo, A Florin-Christensen, Alejo Florin-Christensen +1 · 5 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Antibody #Autoantibody #Autoimmune disease #Autoimmunity #Diabetes Management and Research #Diabetes and associated disorders #Diabetes mellitus #Endocrinology #Immunofluorescence #Immunology #Insulitis #Internal medicine #Islet #Medicine #Pancreatic function and diabetes

paper · doi:10.1016/s0140-6736(74)90140-8

crossref issued 1974/11/01 · crossref published 1974/11/01 · crossref published-print 1974/11/01 · openalex publication_date 1974/11/01 · crossref created 2003/10/11 · crossref deposited 2019/04/17 · openalex created_date 2025/10/10 · crossref indexed 2026/07/03 · openalex updated_date 2026/07/07

Cited by

• Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical onset of Type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years
• Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus
• Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
• Latent autoimmune diabetes in adults [wikipedia]
• Type 1 diabetes [wikipedia]